Aptinyx to Participate in H.C. Wainwright Global Investment Conference
Get Alerts APTX Hot Sheet
Join SI Premium – FREE
EVANSTON, Ill.--(BUSINESS WIRE)-- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced that company management will present at the H.C. Wainwright Global Investment Conference to be held May 23-26, 2022. The presentation will be available on-demand through the H.C. Wainwright conference portal, beginning at 7:00 AM ET on Tuesday, May 24, 2022.
A webcast recording of the presentation will be available to view on the “Events and Presentations” page in the “Investors & Media” section of Aptinyx’s website at https://ir.aptinyx.com and will be archived on Aptinyx’s website for 30 days following the event.
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate—rather than block or over-activate—NMDA receptors and enhance synaptic plasticity, the foundation of neural cell communication. The company has three product candidates in clinical development in central nervous system indications, including fibromyalgia, post-traumatic stress disorder, and cognitive impairment. Aptinyx is also advancing additional compounds from its proprietary discovery platform, which continues to generate a rich and diverse pipeline of small-molecule NMDA receptor modulators with the potential to treat an array of neurologic disorders. For more information, visit www.aptinyx.com or follow Aptinyx on Twitter @Aptinyx.
Source: Aptinyx Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220518005502/en/
Investor and Media Contact:
Patrick Flavin
Aptinyx Inc.
[email protected] or [email protected]
847-871-0377
Source: Aptinyx Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sultan Bin Ahmed Attends Media Master's Graduation in Spain
- After the SpaceX IPO, Investors Are Looking Past Launch — to the Companies That Sell What Satellites See
- Solana Price Prediction Stalls at $70 While Pepeto Presale Gives Early Wallets the Edge
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Twitter, H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share